Analytical Data
-
Gene name
ZNF385D
- Application
-
Alternative Names
ZNF385D; ZNF659; Zinc finger Protein 385D; Zinc finger Protein 659
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9H6B1
-
Expression Region
1-395 aa
-
AA Sequence
MRNIMYFGGT CQSPALPALV RPPAPPLQPS LDIKPFLPFP LDTAAAVNLF PNFNAMDPIQ KAVINHTFGV PLPHRRKQII SCNICQLRFN SDSQAAAHYK GTKHAKKLKA LEAMKNKQKS VTAKDSAKTT FTSITTNTIN TSSDKTDGTA GTPAISTTTT VEIRKSSVMT TEITSKVEKS PTTATGNSSC PSTETEEEKA KRLLYCSLCK VAVNSASQLE AHNSGTKHKT MLEARNGSGT IKAFPRAGVK GKGPVNKGNT GLQNKTFHCE ICDVHVNSET QLKQHISSRR HKDRAAGKPP KPKYSPYNKL QKTAHPLGVK LVFSKEPSKP LAPRILPNPL AAAAAAAAVA VSSPFSLRTA PAATLFQTSA LPPALLRPAP GPIRTAHTPV LFAPY
-
Molecular Weight
42.2 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ZNF385D, a member of the zinc finger protein family, plays a crucial role in various biological processes, including transcriptional regulation, cell proliferation, and apoptosis. Research has highlighted its potential implications in cancer biology, as altered expression of ZNF385D may influence tumor progression and response to therapy. Recent studies have focused on the functional characterization of ZNF385D through recombinant protein expression, which enables the investigation of its structural properties and interactions with other cellular factors. Understanding the mechanisms by which ZNF385D modulates gene expression and its involvement in signaling pathways could provide insights into novel therapeutic strategies. Moreover, the generation of ZNF385D recombinant proteins allows for the development of assays to study its activity and interactions in vitro, helping to elucidate its precise role in both normal physiology and disease states. Consequently, the research surrounding ZNF385D is not only pivotal for expanding our comprehension of zinc finger proteins but also holds promise for advancing cancer research and potential clinical applications.
